Try our Advanced Search for more refined results

March 13, 2017

Alembic Pharmaceuticals Limited v. Novartis AG et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. June 14, 2017

    Alembic Pharma Gets Win In Generic Gilenya Patent Case

    A Virginia federal judge handed Alembic Pharmaceuticals Ltd. a win Tuesday, saying the Indian pharmaceutical company's generic alternative to Novartis AG and Mitsubishi Tanabe Pharma Corp.'s multiple sclerosis drug Gilenya does not infringe their patent.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!